Current location: Home > NEWS > Corporate news
NEWS
PRODUCTS
Good News- SpaceGen passed the 2022 National Inter-laboratory Quality Assessment of Bioinformatics Analysis for High-throughput Sequencing of Tumor Somatic Mutation Detection
News source: Release time:[2022-10-17]
After passing the inter-laboratory quality assessment of high-throughput sequencing detection with full marks for many consecutive years, the quality of spaceGen Medical Inspection has been affirmed again.
Recently, the National Center for Clinical Laboratories (NCCL) of the National Health Commission released the "Statistical Results of Inter-laboratory Quality Evaluation of Bioinformatics Analysis of National High-throughput Sequencing of Tumor Somatic Mutations in 2022". The excellent score of full marks has passed the inter-laboratory quality evaluation of bioinformatics analysis of the NGS platforms of Illumina, Ion torrent and BGI , which fully reflects the bioinformatics analysis capability of SpaceGen Medical Inspection with multiple sequencing platforms. and high-quality analysis level, which also marks that SpaceGen Medical Inspection's bioinformatics analysis and detection capabilities based on next-generation sequencing data have reached the industry-leading level!
Illumina sequencing platform quality assessment results
Ion torrent sequencing platform quality assessment results
BGI sequencing platform quality assessment results
It is understood that the National Inter-laboratory Quality Evaluation Plan for Bioinformatics Analysis of High-throughput Sequencing of Tumor Somatic Mutations is an important means to ensure the quality of clinical laboratory testing. The bioinformatics analysis capability of mutation high-throughput sequencing detection, while discovering common problems in bioinformatics analysis and special problems in some laboratories, so as to promote laboratories to continuously improve the level of bioinformatics analysis.
The full score passed the quality evaluation, which fully reflects the professionalism of SpaceGen in the NSG bioinformatics analysis process and analysis capabilities. In the future, SpaceGen Medical Inspection will contribute to clinical testing with more standardized industry standards, stricter professional requirements and more accurate test results. We will continue to uphold a solid working attitude and strict quality control requirements to provide more accurate tumor genetic testing services for clinical tumor treatment and personal health management.